Every MLR-ready asset your brand needs, made in one studio
Video, docs, social ads, approved email and AI web destinations, generated from your Brand Dossier and claims library, in your brand’s own look, characters and voices. Built to clear review, and to flow straight into Veeva.
Dossier
Approved claims
- CLM-BREV-0012Lowers LDL cholesterol in high-risk adults1
- CLM-BREV-0018Once-daily oral dosing2
- CLM-BREV-0031Fewer major cardiovascular events in BRAVURA-13
- CLM-BREV-0044Most common side effects, as labelled4
Brand kit
Studios
- VideoDrug Explainer
Reel · 60 seconds - DocsDetail Aid
16:9 · 8 pages - AdsBetaSocial Ad
Feed and story - EmailBetaApproved Email
Rep-triggered - WebBetaHCP Portal
5 pages
Everything your brand ships, built from one approved claim
Video, Docs, Ads, Approved Email and Web, each grounded in your verified claims, so a claim reads the same in a video, a detail aid and an email.
Video
Video that explains, persuades and stays on label
Start from a template or a blank brief: explainers, lip-synced doctor avatars and reels, scripted from your verified claims, voiced in your brand and checked before they render.
- Drug explainer
- New drug release
- Clinical results
- Patient handouts
- Field rep training
- Create from scratch
- Avatar: lip-synced doctor presenters
- Reels for mobile
- Broadcast and DTC spots
- Webinar and event video
Docs
Every document a field team and a congress booth needs
Detail aids, infographics and posters built straight from your approved claims, with charts drawn from the cited data and safety information placed where it belongs.
- Visual aids and detail aids
- Sales aids and leave-behinds
- Clinical infographics and charts
- Congress posters, sized to your board
- Flash cards
- Journal ads and print-ready banners
Approved emailBeta
Approved email, built from approved claims
Rep-triggered emails and HCP email campaigns built from approved claims and MLR-ready before they send.
- Rep-triggered email
- HCP email campaigns
- Built from approved claims
- MLR-ready before send
- Multi-touch journeys
Approved Email Approved modulesAI web destinationsBeta
Web destinations your field team can ship the same day
On-label microsites and HCP portals, signed off before publish, with an assistant that answers from your approved content and shows the reference behind every answer.
- HCP portals
- Drug and campaign microsites
- Patient landing pages
- Congress microsites
- Rep sites for the field team
- An assistant grounded in approved content
Everything starts from what is already approved
Every brand you own, its dossiers and every approved claim, in one place. The studios write from these, never around them.
Product Library
Every brand you own, with its photography, dossiers, claims and brand kit in one place.
- BRBrevantaCardiology
6/6 dossiers · 412 claims - VEVelmoraCardiology
4/4 dossiers · 288 claims - ONOnkaviaNSCLC
3/4 dossiers · 351 claims - NINirvexaImmunology
2/3 dossiers · 197 claims
Dossiers for every audience
Six dossiers per brand, each written for its reader: the documents every claim on the brand traces back to.
Written for HCP ScientificReduced major cardiovascular events against standard of care1
Claims Library
Every approved claim across your brands, each with its ID, its market and the source that supports it.
- CLM-BREV-0012ApprovedUSLowers LDL cholesterol in high-risk adultsFDA label
- CLM-BREV-0018ApprovedUSOnce-daily oral dosing, with or without foodFDA label
- CLM-BREV-0103ApprovedEUFewer major cardiovascular events in BRAVURA-1EMA SmPC
- CLM-BREV-0188ApprovedINApproved for adults at high cardiovascular riskCDSCO Approved Drugs (India)
40+ markets, each claim checked against the label that governs it
Your people, your voices, your templates
Cast the faces your brand already uses, narrate in your own team's voices, and start every asset from a layout you have signed off.
Your own characters
People your studios can cast, created from a description or from photographs of a real person. Each is held as a set of views that agree, so the same face turns up in every asset.
ReadyFiona
Company spokesperson
3 sources
ReadyDr. Avery
HCP presenter
1 source
Create new character
From a description, or from photographs
Your own voiceovers
Your team's own voices, cloned from a short recording, and SwishX's stock voices. Each is tagged with its language, with consent kept on file.
- Brevanta narratorCloned · English · Calm
- Medical leadCloned · Spanish · Professional
- SwishX stock voiceEnglish · Warm
Clone a new voice: record 10 to 30 seconds with a teleprompter, or upload a clip.
Subtitles
Captions on every video, timed to the narration and carried into the languages your markets need.
Templates
Start from the product's templates for each studio, or from your own approved layouts, so every asset begins from a design your brand team has signed off.
Ready for review the moment it is made
The studio runs the checks your reviewers would run, before anything leaves it, and every asset can tell you where each line comes from.
94%
first-pass MLR approval
0
uncited claims
- Every claim cited to an approved source
- Checked against the label for each market
- Fair balance and safety information placed for you
- Ask any asset where a line comes from
- An MLR review queue for your reviewers
Studio conversation
Summarise the BRAVURA-1 endpoints as large data callouts for HCPs.
Ask about this infographic
None. Every line on page 1 traces to an approved claim.
CLM-BREV-0012CLM-BREV-0103
- Brevanta · HCP Detail AidDocsIn review
- Brevanta · Drug ExplainerVideoReady for review
- Velmora · HCP InfographicDocsApproved
Built for regulated teams
Everything your studios make, and how it performs
Every asset in progress, in review or finished, in one library, with the numbers that matter: what shipped, how fast it cleared review, and what your audiences read.
All Content
- VIDBrevanta · HCP VideoVideo · 9:16 · 30 secIn progress
- DOCBrevanta · HCP Detail AidDoc / Image · 16:9 · 8 pagesNeed your input
- VIDBrevanta launch filmVideo · Reel · 1:11Published
- DOCBRAVURA-1 at a glanceDoc / Image · Infographic · 16:9Published
Assets shipped
24
Avg. time to MLR approval
3.2 days
Claims verified
98%
Active brand dossiers
18
Output by studio
Top-performing assets
- Real-world evidence for physicians4.6k views
- Dosing guide for physicians4.5k views
- Mechanism of action for endocrinologists3.4k views
Works with the systems you already run
Finished work moves into review and into market through the tools your teams use today. Magic Studio feeds them; it does not replace them.

Veeva PromoMats
Send finished assets into PromoMats for MLR review, with every claim and its reference attached, so reviewers start from a complete package.
- Claims and references travel with the asset
- Review status flows back to the studio

Veeva MedComms
Work from the approved medical content your medical team keeps in MedComms, so medical and promotional materials draw on the same evidence.
- One source of evidence for medical and brand
- Medical content kept in step with the brand

Salesforce
Put rep-triggered content and journeys inside the CRM your field team lives in.
Cortex
Fits the Cortex content workflow from Indegene that many teams and agencies already run.

HubSpot
Run campaign email and landing pages through the marketing tools you already use.
Custom tools
Connect your own systems and data through the SwishX API.
Want to see Magic Studio on your brand?
Bring a brief and your dossier. We will make the first assets with you, in your look, ready for review.
Questions teams ask before they start
What Magic Studio makes, where its content comes from, and how it stays ready for review.
Magic Studio is where your brand team makes every MLR-ready asset: video, docs, ads, approved email and web destinations. Every asset is written from your approved dossiers and claims, by five AI co-workers: a Content Strategist, Medical Writer, MLR Reviewer, Creative Producer and Project Manager.
Still have a question? Talk to us


Social adsBeta
Social and display ads with the fair balance built in
Display, social and journal ads in every size, from one approved message, with important safety information carried in frame rather than added at the end.